(VIANEWS) – First Bank (FRBA), Evercore Partners (EVR), Royal Caribbean Cruises (RCL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Bank (FRBA)
46.3% sales growth and 6.33% return on equity
First Bank provides various banking products and services to individuals, businesses, and governmental entities. The company accepts various deposits, including non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts, and certificates of deposit, as well as commercial checking accounts. Its loan products include commercial and industrial loans; commercial real estate loans, such as owner-occupied, investor, construction and development, and multi-family loans; residential real estate loans comprising residential mortgages, first and second lien home equity loans, and revolving lines of credit; and consumer and other loans that include auto, personal, and traditional installment loans. The company also provides electronic banking services, including Internet and mobile banking, electronic bill payment, and banking by phone, as well as ATM and debit cards, and wire and ACH transfer services; remote deposit capture; and cash management services. As of December 31, 2021, it operated 18 full-service branches in Cinnaminson, Cranbury, Delanco, Denville, Ewing, Flemington, Hamilton, Hamilton, Lawrence, Mercerville, Pennington, Randolph, Somerset, and Williamstown counties in New Jersey, as well as Doylestown, Trevose, Warminster, and West Chester counties in Pennsylvania. First Bank was incorporated in 2007 and is headquartered in Hamilton, New Jersey.
Earnings Per Share
As for profitability, First Bank has a trailing twelve months EPS of $1.05.
PE Ratio
First Bank has a trailing twelve months price to earnings ratio of 13.9. Meaning, the purchaser of the share is investing $13.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.33%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 95.86M for the twelve trailing months.
Yearly Top and Bottom Value
First Bank’s stock is valued at $14.60 at 05:22 EST, below its 52-week high of $15.17 and way higher than its 52-week low of $8.59.
2. Evercore Partners (EVR)
26% sales growth and 16.87% return on equity
Evercore Inc., together with its subsidiaries, operates as an independent investment banking advisory firm in the United States, Europe, Latin America, and internationally. It operates through two segments, Investment Banking and Investment Management. The Investment Banking segment offers strategic advisory services, such as mergers and acquisitions, strategic, defense, and shareholder advisory, special committee assignments, and transaction structuring; Capital Markets Advisory, including equity capital markets, restructuring, debt advisory, private placement advisory, market risk management and hedging, private capital advisory, and private funds; and research, sales, and trading professionals services on a content-led platform to its institutional investor clients. The Investment Management segment provides wealth management services to high-net-worth individuals, foundations, and endowments; and manages financial assets for institutional investors. The company was formerly known as Evercore Partners Inc. and changed its name to Evercore Inc. in August 2017. Evercore Inc. was founded in 1995 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Evercore Partners has a trailing twelve months EPS of $6.37.
PE Ratio
Evercore Partners has a trailing twelve months price to earnings ratio of 28.02. Meaning, the purchaser of the share is investing $28.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.87%.
3. Royal Caribbean Cruises (RCL)
16.1% sales growth and 43.87% return on equity
Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 13, 2023, it operated 64 ships. The company was founded in 1968 and is headquartered in Miami, Florida.
Earnings Per Share
As for profitability, Royal Caribbean Cruises has a trailing twelve months EPS of $6.31.
PE Ratio
Royal Caribbean Cruises has a trailing twelve months price to earnings ratio of 18.43. Meaning, the purchaser of the share is investing $18.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.87%.
Sales Growth
Royal Caribbean Cruises’s sales growth is 21.1% for the present quarter and 16.1% for the next.
Previous days news about Royal Caribbean Cruises(RCL)
- The zacks analyst blog highlights acushnet, royal caribbean cruises, Carnival, universal technical institute and corsair. According to Zacks on Monday, 12 February, "Stocks recently featured in the blog include: Acushnet (GOLF Quick QuoteGOLF – Free Report) , Royal Caribbean Cruises (RCL Quick QuoteRCL – Free Report) , Carnival (CCL Quick QuoteCCL – Free Report) , Universal Technical Institute (UTI Quick QuoteUTI – Free Report) and Corsair Gaming (CRSR Quick QuoteCRSR – Free Report) ."
4. Amazon (AMZN)
11.7% sales growth and 17.49% return on equity
Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.
Earnings Per Share
As for profitability, Amazon has a trailing twelve months EPS of $2.9.
PE Ratio
Amazon has a trailing twelve months price to earnings ratio of 58.73. Meaning, the purchaser of the share is investing $58.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.49%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 574.78B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amazon’s EBITDA is 3.24.
Previous days news about Amazon(AMZN)
- Apple, Amazon, Microsoft, meta and NVIDIA are part of zacks earnings preview. According to Zacks on Monday, 12 February, "This week’s list includes Apple (AAPL Quick QuoteAAPL – Free Report) , Amazon (AMZN Quick QuoteAMZN – Free Report) , Microsoft (MSFT Quick QuoteMSFT – Free Report) , Meta (META Quick QuoteMETA – Free Report) and Nvidia (NVDA Quick QuoteNVDA – Free Report) .", "But strictly speaking, not all of them are in the Tech sector, as we at Zacks have Amazon as part of the Zacks Retail sector and Tesla as part of the Zacks Auto sector."
- According to FXStreet on Monday, 12 February, "NASDAQ Stock market Elliott Wave analysis and trading strategies: NASDAQ 100, Apple (AAPL), Tesla (TSLA), Amazon (AMZN), Nvidia (NVDA), Microsoft (MSFT), Meta Platforms (META), Netflix (NFLX), Alphabet (GOOGL).", "00:00 NASDAQ 100 (NDX) 06:46 Apple (AAPL) 11:28 Amazon (AMZN) 15:07 Meta Platforms (META) 18:03 NVIDIA (NVDA) 20:22 Netflix (NFLX) 21:31 Alphabet (GOOGL) 23:01 Microsoft MSFT 24:20 Tesla (TSLA)"
5. The Ensign Group (ENSG)
11.3% sales growth and 18.78% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $4.34.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 26.85. Meaning, the purchaser of the share is investing $26.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.78%.
Volume
Today’s last reported volume for The Ensign Group is 218869 which is 11.47% below its average volume of 247242.
6. Erie Indemnity Company (ERIE)
11% sales growth and 26.99% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $7.66.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 44.73. Meaning, the purchaser of the share is investing $44.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.99%.
Moving Average
Erie Indemnity Company’s worth is higher than its 50-day moving average of $319.21 and way above its 200-day moving average of $269.11.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 4, 2024, the estimated forward annual dividend rate is 5.1 and the estimated forward annual dividend yield is 1.49%.
Sales Growth
Erie Indemnity Company’s sales growth is 10.3% for the present quarter and 11% for the next.
7. Zoetis (ZTS)
9.6% sales growth and 46.78% return on equity
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Earnings Per Share
As for profitability, Zoetis has a trailing twelve months EPS of $5.06.
PE Ratio
Zoetis has a trailing twelve months price to earnings ratio of 36.35. Meaning, the purchaser of the share is investing $36.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.78%.
Previous days news about Zoetis(ZTS)
- According to Zacks on Monday, 12 February, "Let’s see how things have shaped up for Biogen Inc. (BIIB Quick QuoteBIIB – Free Report) , Zoetis Inc. (ZTS Quick QuoteZTS – Free Report) and Incyte Corporation (INCY Quick QuoteINCY – Free Report) ahead of their fourth-quarter 2023 results. ", "Our proven model predicts an earnings beat for Zoetis in the to-be-reported quarter."
- Zoetis (zts) Q4 earnings lag estimates. According to Zacks on Tuesday, 13 February, "While Zoetis has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Compared to estimates, zoetis (zts) Q4 earnings: A look at key metrics. According to Zacks on Tuesday, 13 February, "Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
- Zoetis' (zts) Q4 earnings miss expectations, sales beat. According to Zacks on Tuesday, 13 February, "Shares of Zoetis have gained 20.6% in the past year against theindustry’s 2.8% decline."
8. LeMaitre Vascular (LMAT)
7.1% sales growth and 9.92% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.22.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 47.74. Meaning, the purchaser of the share is investing $47.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.92%.
Moving Average
LeMaitre Vascular’s value is above its 50-day moving average of $55.44 and above its 200-day moving average of $57.65.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 14, 2023, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 0.96%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
LeMaitre Vascular’s EBITDA is 98.45.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 44% and 29.6%, respectively.
